Unisafe Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.50 M
as on 05-07-2024
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 22.65%
(FY 2021)
- Profit 172.51%
(FY 2021)
- Ebitda 34.88%
(FY 2021)
- Net Worth 6.42%
(FY 2021)
- Total Assets 32.25%
(FY 2021)
About Unisafe Bioscience
The Corporate was formerly known as Crystal Formulations Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Hussain Rangwala and Rashid Rangwala serve as directors at the Company.
- CIN/LLPIN
U24230GJ1993PTC019290
- Company No.
019290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Unisafe Bioscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hussain Rangwala  | Director | 01-Dec-2010 | Current |
| Rashid Rangwala | Director | 15-Apr-1993 | Current |
Financial Performance of Unisafe Bioscience.
Unisafe Bioscience Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 22.65% increase. The company also saw a substantial improvement in profitability, with a 172.51% increase in profit. The company's net worth moved up by a moderate rise of 6.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unisafe Bioscience?
In 2021, Unisafe Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gujarat Medicraft Private LimitedActive 34 years 5 monthsHussain Rangwala and Rashid Rangwala are mutual person
Safeway Lifesciences Private LimitedActive 18 years 5 monthsHussain Rangwala and Rashid Rangwala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unisafe Bioscience?
Unlock and access historical data on people associated with Unisafe Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unisafe Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unisafe Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
